AFP and hepatocellular carcinoma: Compared to patients with cirrhosis, those with HCC had higher median values of AFP (31.8 vs. 3.0 ng/mL), AFP-L3 (5.7 vs. 1.2%), and DCP (446.4 vs. 46.6 ng/mL) (p < 0.001 for all) (Supplemental Figure S1).